Edition:
United Kingdom

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

88.93USD
18 Jun 2018
Change (% chg)

$-0.27 (-0.30%)
Prev Close
$89.20
Open
$88.50
Day's High
$89.18
Day's Low
$88.41
Volume
589,034
Avg. Vol
692,087
52-wk High
$89.25
52-wk Low
$59.64

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $31,180.87
Shares Outstanding(Mil.): 489.11
Dividend: 0.10
Yield (%): 0.66

Financials

  ZTS.N Industry Sector
P/E (TTM): 36.00 30.95 32.75
EPS (TTM): 1.77 -- --
ROI: 14.09 14.84 14.38
ROE: 57.16 16.34 16.07

Healthcare investors weigh bets as election risks loom

NEW YORK If 2016 is any guide, pharmaceutical, biotech and other healthcare stocks could be in for a rough summer and fall heading into another round of U.S. elections.

01 Jun 2018

Wall St Week Ahead-Healthcare investors weigh bets as election risks loom

NEW YORK, June 1 If 2016 is any guide, pharmaceutical, biotech and other healthcare stocks could be in for a rough summer and fall heading into another round of U.S. elections.

01 Jun 2018

Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion

Top animal health company Zoetis Inc will buy Abaxis Inc for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics services that cater to household pets and farm animals.

16 May 2018

Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion

Top animal health company Zoetis Inc will buy Abaxis Inc for $1.9 billion, looking to capture a bigger slice of the fast-growing market for diagnostics services that cater to household pets and farm animals.

16 May 2018

REFILE-UPDATE 5-Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 bln

* Zoetis says diagnostics should grow faster than animal health

16 May 2018

BRIEF-Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis

* ZOETIS SAYS UPON DEAL TERMINATION BY ABAXIS OR CO, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY ABAXIS - SEC FILING Source text: (https://bit.ly/2KprpqL) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

16 May 2018

BRIEF-Zoetis To Acquire Abaxis for about $2 Bln In Aggregate

* ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS

16 May 2018

Zoetis to buy Abaxis for $1.9 bln in cash

May 16 Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.

16 May 2018

BRIEF-Zoetis Announces Q1 Earnings Per Share $0.72

* Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S

02 May 2018

BRIEF-Zoetis Inc To Expand Animal Vaccine Research And Manufacturing In Suzhou, China

* ZOETIS INC SAYS TO EXPAND ANIMAL VACCINE RESEARCH AND MANUFACTURING IN SUZHOU, CHINA Source text for Eikon: Further company coverage:

26 Apr 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $60.99 -1.04
Bayer AG (BAYGn.DE) €96.60 -1.86
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €67.53 -0.72
Eli Lilly And Co (LLY.N) $86.11 -0.77

Earnings vs. Estimates